Hepatic steatosis: a risk factor for increased COVID-19 prevalence and severity—a computed tomography study

BACKGROUND: Around 25% of the world population was affected by the metabolic-related fatty liver disorder. Hepatic steatosis is frequently observed in conjunction with hypertension, obesity comorbidities, and diabetes. We evaluate the hepatic steatosis frequency found in chest CT exams of COVID-19-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Asmaa, Hasan, Mona, Hamed, Shaimaa, Elhamy, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274961/
https://www.ncbi.nlm.nih.gov/pubmed/34777870
http://dx.doi.org/10.1186/s43066-021-00131-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274961/
https://www.ncbi.nlm.nih.gov/pubmed/34777870
http://dx.doi.org/10.1186/s43066-021-00131-6

Ejemplares similares